Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Finland
/
Healthcare
/
Modulight Oyj
MODU
Modulight Oyj
Delayed Approvals Will Hamper Precision Medicine Despite Future Promise
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 2 Analysts
Published
17 Aug 25
Updated
17 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€1.50
14.0% undervalued
intrinsic discount
17 Aug
€1.29
Loading
1Y
12.2%
7D
5.7%
Author's Valuation
€1.5
14.0% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€1.5
14.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-11m
18m
2020
2021
2022
2023
2024
2025
2026
2027
2028
Revenue €17.7m
Earnings €2.9m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
27.11%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.36%
Calculation
€2.87m
Earnings '28
x
22.60x
PE Ratio '28
=
€64.96m
Market Cap '28
€64.96m
Market Cap '28
/
34.54m
No. shares '28
=
€1.88
Share Price '28
€1.88
Share Price '28
Discounted to 2025 @ 6.36% p.a.
=
€1.56
Fair Value '25
